Haustein K O, Hentschel C, Hentschel H
Institute of Clinical Pharmacology, Medical Academy Erfurt, GDR.
Int J Clin Pharmacol Ther Toxicol. 1987 Dec;25(12):651-5.
By the use of the phosphate method the activity of the (Na+ + K+)-ATPase system (E. C. 3.1.6.1.) of human left ventricle was measured in one tissue sample each obtained from 47 autopsied patients. The subjects between the ages of 20 and 79 years had suffered from congestive heart failure of different functional classes NYHA), from diseases of the heart and circulation, or from tumors. Only 23 of the patients of the entire group took digitalis glycosides. With the exception of one sample (8.58 mumol Pi.mg-1.h-1), the enzyme activity amounted from 0.45 to 4.84 mumol Pi.mg-1. The ATPase activity depends on the age (A), the functional classes of congestive heart failure (CF; CF greater than A), and the time between death and autopsy. Chronic hypoxic alterations decreased the enzyme activity. Digitalization did not influence the post-mortem enzyme activity. Due to the small therapeutic range of digitalis glycosides and a distinctly reduced ATPase activity of the ageing patient, enhanced glycoside maintenance doses will not improve myocardial contractility, but provoke arrhythmias.
采用磷酸法,对47例尸检患者的每一份左心室组织样本测定了人左心室(Na+ + K+)-ATP酶系统(E.C. 3.1.6.1.)的活性。年龄在20至79岁之间的受试者患有不同功能分级(纽约心脏协会分级)的充血性心力衰竭、心脏和循环系统疾病或肿瘤。整个组中只有23例患者服用洋地黄苷。除一个样本(8.58微摩尔无机磷·毫克-1·小时-1)外,酶活性为0.45至4.84微摩尔无机磷·毫克-1。ATP酶活性取决于年龄(A)、充血性心力衰竭的功能分级(CF;CF大于A)以及死亡与尸检之间的时间。慢性缺氧改变会降低酶活性。洋地黄化不影响死后酶活性。由于洋地黄苷的治疗范围窄,且老年患者的ATP酶活性明显降低,增加苷类维持剂量不会改善心肌收缩力,反而会引发心律失常。